World's Best Scientists 2026 revealed!
Richard Quintiliani

Richard Quintiliani

D-Index & Metrics

Microbiology

D-Index
52
Citations
9486
World Ranking
4218
National Ranking
1634

Richard Quintiliani publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Richard Quintiliani sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 229 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Richard Quintiliani D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Quintiliani sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 52 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Richard Quintiliani is affiliated with Hartford Hospital in the United States. Their research primarily spans fields related to medicine, with additional contributions to biochemistry, genetics, and molecular biology. Subfields within their work include pharmacology, pediatrics, perinatology, child health, and molecular medicine.

Their scholarly output includes publications focusing on antibiotics pharmacokinetics and efficacy, pharmaceutical studies and practices, and antibiotic resistance in bacteria.

  • Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding (2022), Journal of Antimicrobial Chemotherapy

Frequent collaborators in their research include:

  • Aliaa Fouad
  • David P. Nicolau
  • Tomefa E. Asempa

Their work has been published in venues such as:

  • Journal of Antimicrobial Chemotherapy

Best Publications

  • A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

    R L Greenman;R M Schein;M A Martin;R P Wenzel

  • Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.

    D P Nicolau;C D Freeman;P P Belliveau;C H Nightingale

  • Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant staphylococcus aureus at a large community hospital

    Joseph J. Klimek;Frederick J. Marsik;Raymond C. Bartlett;Barbara Weir

  • Pharmacokinetics and Clinical Use of Cephalosporin Antibiotics

    Charles H. Nightingale;Douglas S. Greene;Richard Quintiliani

  • Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

    Melinda K. Lacy;Wen Lu;Xiaowei Xu;Pamela R. Tessier

  • The pharmacodynamics of aminoglycosides

    Melinda K. Lacy;David P. Nicolau;Charles H. Nightingale;Richard Quintiliani

  • Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.

    David P Nicolau;JoCarol McNabb;Melinda K Lacy;Richard Quintiliani

  • The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci.

    Richard Quintiliani;Stefan Evers;Patrice Courvalin

  • Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin

    Unknown

  • Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial.

    Michael N. Dudley;James C. McLaughlin;George Carrington;Jean Frick

  • Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.

    Edward M. Grant;Joseph L. Kuti;David P. Nicolau;Charles Nightingale

  • Regulation of VanA- and VanB-type glycopeptide resistance in enterococci.

    Michel Arthur;Richard Quintiliani

  • Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome

    Richard Quintiliani;Patrice Courvalin

  • Mechanisms of glycopeptide resistance in enterococci

    M. Arthur;P.E. Reynolds;F. Depardieu;S. Evers

  • Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281

    Unknown

  • Economic impact of streamlining antibiotic administration.

    R Quintiliani;B W Cooper;L L Briceland;C H Nightingale

  • Trimethoprim-Sulfamethoxazole for Bacterial Meningitis

    Robert E. Levitz;Richard Quintiliani

  • The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement.

    BA Cunha;HR Gossling;HS Pasternak;CH Nightingale

  • Vancomycin Therapeutic Drug Monitoring: Is it Necessary?

    Dennis F. Thompson;Marsha A. Raebel;Collin D. Freeman;Richard Quintiliani

  • The CroRS Two-Component Regulatory System Is Required for Intrinsic β-Lactam Resistance in Enterococcus faecalis

    Yannick Comenge;Richard Quintiliani;Richard Quintiliani;Ling Li;Lionnel Dubost

  • Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.

    D P Nicolau;C H Nightingale;M A Banevicius;Q Fu

  • Penetration of Amoxicillin, Cefaclor, Erythromycin-Sulfisoxazole, and Trimethoprim-Sulfamethoxazole into the Middle Ear Fluid of Patients with Chronic Serous Otitis Media

    P. J. Krause;N. J. Owens;C. H. Nightingale;J. J. Klimek

  • Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa.

    Jianguo Zhi;Jianguo Zhi;Charles H. Nightingale;Charles H. Nightingale;Richard Quintiliani;Richard Quintiliani

  • Pharmacokinetics of Vancomycin in Anuria

    B. A. Cunha;R. Quintiliani;J. M. Deglin;M. W. Izard

  • Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis.

    D P Nicolau;C D Freeman;C H Nightingale;R Quintiliani

  • Clinical Pharmacokinetics of Ceftriaxone

    Jae H. Yuk;Charles H. Nightingale;Richard Quintiliani

  • Pneumonia Due to Pseudomonas aeruginosa: Part II: Antimicrobial Resistance, Pharmacodynamic Concepts, and Antibiotic Therapy

    Hsin-Yun Sun;Shigeki Fujitani;Richard Quintiliani;Victor L. Yu

  • Treatment of nocardial infection with trimethoprim and sulfamethoxazole

    Eufronio G. Maderazo;Richard Quintiliani

Frequent Co-Authors

Charles H. Nightingale
Charles H. Nightingale University of Connecticut
David P. Nicolau
David P. Nicolau Hartford Hospital
Michael N. Dudley
Michael N. Dudley Qpex Biopharma
Joseph L. Kuti
Joseph L. Kuti Hartford Hospital
José Pontón
José Pontón University of the Basque Country
John G. Bartlett
John G. Bartlett Johns Hopkins University School of Medicine
Josep Guarro
Josep Guarro Rovira i Virgili University
Javier Pemán
Javier Pemán Hospital Universitari i Politècnic La Fe
Guillermo Quindós
Guillermo Quindós University of the Basque Country

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, diverse career pathways extend beyond traditional laboratory roles. One promising avenue is healthcare, where professionals with scientific backgrounds can explore specialized roles. For example, becoming a functional medicine nurse practitioner merges patient care with a strong foundation in biological sciences, offering a dynamic and patient-focused career.

Additionally, the healthcare industry increasingly relies on accurate data management. A career as a certified professional coder (CPC) involves translating medical information into codes for billing and analysis, requiring specialized training accessible through online courses.

For those interested in overseeing health data and improving healthcare systems, roles like a health information manager salary highlight attractive earning potential and leadership opportunities. Pursuing degrees in health information management through the best CAHIIM accredited HIM programs online provides the essential knowledge and credentials needed to succeed in this field.

Exploring these online degrees and career pathways can enhance a microbiology graduate’s versatility, bridging biological expertise with healthcare and information management for a rewarding professional journey.

Best Scientists Citing Richard Quintiliani

Trending Scientists

Recently Published Articles